Autonomix Medical, Inc. (AMIX) vs Moleculin Biotech, Inc. (MBRX)
A side-by-side comparison of Autonomix Medical, Inc. and Moleculin Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMIX
Autonomix Medical, Inc.
$3.55HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
MBRX
Moleculin Biotech, Inc.
$0.44HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AMIX vs MBRX
growth of $100 · dividends reinvested · last 3yAMIX -99.8% (-88.2%/yr)MBRX -99.7% (-86.3%/yr)MBRX compounded faster over this window
AMIX MBRX
AMIX vs MBRX: by the numbers
- •MBRX is the larger company ($2M vs $2M market cap).
Metrics side by side
Valuation
| Metric | AMIX | MBRX |
|---|---|---|
| P/B ratio | 0.61 | 0.20 |
Profitability
| Metric | AMIX | MBRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -509.36% | -261.73% |
| ROIC | -518.15% | -242.25% |
Growth (annualized)
| Metric | AMIX | MBRX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -78.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.